Contact Nebraska Medicine cancer hotline today at 800.999.5465.
Learn more about clinical trials at this NCCN Member Institution.
The mission of the Fred & Pamela Buffett Cancer Center is to coordinate cancer care, research and education in Nebraska, the region and the world.
Respected for decades as the Eppley Cancer Center, the new name, Fred & Pamela Buffett Cancer Center, and its future home, create greater possibilities for cancer research and care.
Currently under construction, the new Fred & Pamela Buffett Cancer Center facility is scheduled to open in 2017. Health care providers and researchers will work side-by-side in state-of-the-art, integrated facilities to speed up breakthroughs in the lab and ensure personalized patient care. The largest project ever on campus, the $323 million facility will include a 252,000 square foot cancer research tower and 323,000 square foot clinical treatment facility which includes ambulatory and inpatient services.
As the only National Cancer Institute-designated cancer center in Nebraska, the Fred & Pamela Buffett Cancer Center provides the best in science and clinical practice. Today, more than 200 oncologists and basic scientists are working together to find better ways to diagnose, treat and prevent cancer.
For over 50 years, our scientists and physicians have been at the forefront of discoveries that have increased survivorship. We’ve treated people from all 50 states and more than 42 different countries. Our strengths in lymphoma, leukemia, breast cancer, pancreatic and gastrointestinal cancers, head and neck cancers, brain cancer, lung cancer, pediatric oncology and research have meant unmatched care for Nebraska, the region and the world.
ACCREDITATION & AWARDS
Considered to be a Center of Excellence for the study of lymphoma, much emphasis is placed on integrated laboratory and clinical research in this disease. The Center's Lymphoma Study Group has reviewed more than 40,000 biopsies and created a clinical outcome database to correlate the findings. Nebraska Medicine’s stem cell transplantation program has been ranked as one of the busiest adult and pediatric stem cell transplantation programs in the world. The program, which was established in 1983, has been recognized internationally for pioneering autologous transplantation for lymphoma, using peripheral stem cells as an alternative rescue product; conducting ground-breaking transplant studies; and performing transplants in alternate settings other than traditional inpatient hospital units.
The Fred & Pamela Buffett Cancer Center has a $5.3 million National Cancer Institute Specialized Program of Research Excellence (SPORE) grant in pancreatic cancer. SPORE offers large, multidisciplinary federal grants that fund scientific research aimed at bringing new laboratory findings quickly to the clinic.
Nationally recognized breast cancer researchers along with a strong nucleus of established breast cancer researchers at UNMC, enable the Cancer Center to create a Center for Breast Cancer Research that will transform the breast cancer research program at the Fred & Pamela Buffett Cancer Center into a world-class research program for breast cancer detection, prevention, and treatment.
Stem Cell Transplant Program:
The diseases most treated using stem cell transplantation are non-Hodgkin's lymphoma, Hodgkin's lymphoma, leukemia, multiple myeloma and solid tumors (including breast cancer or testicular cancer). Various other hematological and non-hematological diseases are treated on a case by case basis. Autologous, related and unrelated myeloablative allogeneic, related and unrelated non-myeloablative, and cord blood transplants are provided for adults and children. The program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).
The Fred & Pamela Buffett Cancer Center offers radiation therapy as a highly effective and targeted cancer therapy used in 70 percent of all cancer patients. Revolutionary advances in Radiation Oncology have been made over the past 10-15 years. More precise and targeted therapy delivery and improvements in imaging help physicians spare normal tissues to a greater degree than in past years. Radiation therapy is often used in conjunction with other treatment modalities, such as surgery or chemotherapy, or can be used as the sole treatment modality.
The Fred & Pamela Buffett Cancer Center has a robust surgical oncology program offering patients unique treatment options not available elsewhere. The program offers a comprehensive approach to cancer care with the largest number of fellowship-trained surgical oncologists in the Midwest. Several areas of surgical therapies are available at the Fred & Pamela Buffett Cancer Center including gastrointestinal, orthopaedic, urologic, thoracic, gynecologic, head and neck, plastic and reconstructive and neuro-oncology.
EXCELLENCE IN RESEARCH
Research efforts are organized into four main research programs which facilitate collaboration between basic science and clinical researchers through participation in program activities and focus group meetings. The Fred & Pamela Buffett Cancer Center research programs include: